Page last updated: 2024-10-26

dyphylline and Chemical and Drug Induced Liver Injury, Chronic

dyphylline has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 3 studies

Dyphylline: A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.
dyphylline : An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.

Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Chalasani, N3
Bonkovsky, HL2
Stine, JG1
Gu, J3
Barnhart, H3
Jacobsen, E1
Björnsson, E1
Fontana, RJ2
Kleiner, DE2
Hoofnagle, JH2
Devarbhavi, H1
Ghabril, M1
Patil, M1
Raj, S1
Li, YJ1
Dellinger, A1
Navarro, V1
Bonkovsky, H1
Phillips, E1
Lammert, C1
Schwantes-An, TH1
Nicoletti, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury[NCT00345930]4,000 participants (Anticipated)Observational2004-09-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for dyphylline and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
    Journal of hepatology, 2022, Volume: 76, Issue:4

    Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Chemical and Drug Ind

2022
Leflunomide-induced liver injury: Differences in characteristics and outcomes in Indian and US registries.
    Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Drug-Relate

2022
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
    Journal of hepatology, 2023, Volume: 78, Issue:2

    Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Dyphylline;

2023